On closing, merged company to combine innovative medical business, low-cost cultivation, specialized craft cannabis, micropropagation, and solventless...
Company reports results of Annual General & Special Meeting of Shareholders held on June 30, 2021 which includes overwhelming shareholder approval...
WeedMD announced today its financial results for the three months ended March 31, 2021....
Award-winning adult-use brand Color now available coast-to-coast in 90% of Canada’s retail markets...
Closes share-sale transaction with Final Bell Canada Inc. following Starseed Medicinal’s full production and product fulfillment move to Company’s consolidated London-area facilities...
WeedMD is pleased to announce it has signed a Letter of Intent to acquire all of the issued and outstanding shares of renowned craft cultivator CannTx Life Sciences Inc...
WeedMD announced today its financial results for the fiscal year ended December 31, 2020....
Our Chief People Officer Deborah Sikkema, opens the conversation around mental health to increase awareness and accessibility through May and beyond....
Company financials to be filed after market on May 28, 2021 and operational outlook to be provided during call, including first quarter 2021 record milestones achieved...
Company expands into premium craft offering with exclusive licensing for ‘Limited Edition’ high-THC craft strains Rockstar Tuna and Royal Goddess for Starseed patients...
